Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/cap.2009.0009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Methylphenidate Induced Lip and Tongue Biting.
Clin Psychopharmacol Neurosci
May 2018
Department of Psychiatry, Adıyaman University Research and Education Hospital, Adıyaman, Turkey.
Attention deficit hyperactivity disorder (ADHD) is a life-long neurodevelopmental disorder and treatment depends on pharmacotherapy because of its biological origin. Stimulant drugs are the most commonly used treatment for ADHD and they have various side effects. Herein, we report a case who bit off the tip of her tongue with Osmotic Release Oral System methylphenidate (OROS MPH) 36 mg/day, bit the tip of her lower lip with immediate release (IR) MPH 10 mg/day and lateral part of her tongue with IR MPH 20 mg/day.
View Article and Find Full Text PDFOROS-Methylphenidate-Induced Raynaud's Phenomenon: A Dose-Related Side Effect.
J Child Adolesc Psychopharmacol
August 2015
Department of Child and Adolescent Psychiatry, Meram Faculty of Medicine, Necmettin Erbakan University, Meram, Konya, Turkey .
Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
J Clin Psychopharmacol
June 2013
Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University, College of Medicine, Seoul, Korea.
Noradrenergic dysfunction may be associated with cognitive impairments in attention-deficit/hyperactivity disorder (ADHD), including increased response time variability, which has been proposed as a leading endophenotype for ADHD. The aim of this study was to examine the relationship between polymorphisms in the α-2A-adrenergic receptor (ADRA2A) and norepinephrine transporter (SLC6A2) genes and attentional performance in ADHD children before and after pharmacological treatment.One hundred one medication-naive ADHD children were included.
View Article and Find Full Text PDFRisk of methylphenidate-induced prehypertension in normotensive adult smokers with attention deficit hyperactivity disorder.
J Clin Hypertens (Greenwich)
February 2013
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390-8828, USA.
The authors studied predictors of methylphenidate-induced increases in blood pressure (BP). In this secondary analysis of a randomized, double-blind, placebo-controlled smoking cessation trial, nonhypertensive adult smokers with attention deficit hyperactivity disorder randomized to osmotic-release oral system methylphenidate (OROS-MPH) (n=115) were matched one-to-one on baseline systolic BP (SBP) (±5 mm Hg) with participants randomized to placebo (n=115) and followed for 10 weeks. In adjusted mixed linear models of SBP and diastolic BP (DBP), baseline normal SBP (P<.
View Article and Find Full Text PDFOsmotic release oral system (OROS) Methylphenidate-induced double incontinence: a case report.
Prim Care Companion J Clin Psychiatry
August 2012
Department of Child and Adolescent Psychiatry, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine ; and Institute of Biomedical Sciences, Academia Sinica , Taiwan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!